Safety of TEG001 in patients with r/r AML/high-risk MDS or r/r MM
NL58686.000.16
Phase 1 other active
Quick answer
Safety of TEG001 in patients with r/r AML/high-risk MDS or r/r MM for Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM) is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM)
- Phase
- Phase 1
- Modality
- other
- Status
- active